Zhiwei Wang

Zhengzhou University

100 Science Avenue

Zhengzhou, Henan 450001

China

SCHOLARLY PAPERS

2

DOWNLOADS

20

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Role of Immune Checkpoint Inhibitor-Based Therapies for Metastatic Renal Cell Carcinoma in the First-Line Setting: A Systematic Review and Bayesian Network Analysis

Number of pages: 36 Posted: 18 Jun 2019
Zhengzhou University, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology and Zhengzhou University - Department of Urology
Downloads 10 (622,643)

Abstract:

Loading...

renal cell carcinoma; first-line systemic therapies; immune checkpoint inhibitor; efficacy; safety

2.

First-Line Systemic Treatments for Advanced/Metastatic Renal Cell Carcinoma of Favorable-, Intermediate-, and Poor-Risk, Respectively: A Bayesian Network Analysis

Number of pages: 36 Posted: 28 Jan 2019
Zhengzhou University, Zhengzhou University, Zhengzhou University, Jilin University (JLU), Jilin University (JLU), Jilin University (JLU), Zhengzhou University - Zhengzhou Central Hospital, Zhengzhou University - Department of Urology and Zhengzhou University - Department of Urology
Downloads 10 (622,643)

Abstract:

Loading...

renal cell carcinoma; systemic therapy; risk stratification; efficacy; safety